Washington, DC—Sept 23, 2011…On October 4 & 5, 2011, Women Against Prostate Cancer will hold its 2nd annual “Prostate Cancer Advocacy Day” conference. Women from across the country will meet on Tuesday, October 4, at the Hyatt Regency Crystal City in Arlington, VA for a prostate cancer briefing and advocacy training. On Wednesday, October 5, they will head to Capitol Hill to meet with legislators and advocate for increased awareness and funding for prostate cancer.
“September was “Prostate Cancer Awareness Month,” but the efforts to educate men and women about prostate cancer are continuing to move forward,” saidTheresa Morrow, President and Co-Founder of Women Against Prostate Cancer (WAPC). “It is estimated that this year alone over 240,000 men will be diagnosed and approximately 33,000 men will die of prostate cancer, with African-American men dying at twice the rate of the general population. Women are also impacted by the disease, and we have to be pro-active to educate the men in our lives, as well as those who can help fund research and awareness efforts.”
Speakers at the prostate cancer briefing include Isaac Kim, MD, PhD, Executive Director, Dean and Betty Gallo Prostate Cancer Center at The Cancer Institute of New Jersey (CINJ) and Associate Professor of Surgery at UMDNJ-Robert Wood Johnson Medical School; Darlene Haywood, Essence of WellnessHealthCoaching; Betty Gallo, Co-Founder Women Against Prostate Cancer and Director of Government Relations and Outreach for the Dean and Betty Gallo Prostate Cancer Center at CINJ; J. Leslie Boucrée, Legislative Assistant, Office of Congressman Edolphus Towns; Victoria Hallerman, author, “How We Survived Prostate Cancer;” and Rebecca Perkins, The Perkins Partnership.
On Wednesday, October 5, conference attendees will attend a luncheon with Cong. Jon Runyan (R-NJ), Cong. Heath Shuler (D-NC) and Cong. Rodney Frelinghuysen (R-NJ) speaking on their efforts to advance funding and awareness of prostate cancer research. They will also meet with individual legislators throughout the day.
The conference is free, and assistance may be available to cover transportation and lodging costs. More information can be found about the event at www.womenagainstprostatecancer.org. Dendreon Corporation and Janssen Pharmaceuticals, Inc. are sponsors of the event.
“Early detection and treatment of prostate cancer leads to a nearly 100 percent survival rate. If men and women had the same awareness of prostate cancer as they do of breast cancer, we would have the potential to save thousands of lives in this country each year,” Morrow said.
Women Against Prostate Cancer (WAPC) is a national organization working to unite the voices and provide support for the millions of women and their families affected by prostate cancer. WAPC advocates prostate cancer education, public awareness, screenings, legislation, and treatment options. Members of the group represent over 20 states and a variety of backgrounds and expertise. To learn more, visit us online at www.womenagainstprostatecancer.org.